PEDIATRICS Vol. 26 No. 3 September 1960, pp. 368-374
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by James, J. A.
Right arrow Articles by Combes, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by James, J. A.
Right arrow Articles by Combes, M.

IRON DEFICIENCY IN THE PREMATURE INFANT

Significance, and Prevention by the Intramuscular Administration of Iron-dextran

John A. James M.B., M.R.C.P.1 and Mollie Combes M.D.1

1 Department of Pediatrics, University of Texas Southwestern Medical School, and Parkland Memorial Hospital, Dallas

Iron-dextran was given intramuscularly to 84 small prematurely born babies during their stay in the nursery; 97 similar babies were not so treated and served as controls.

By 8 to 10 weeks of age, values for hemoglobin in the babies who received iron-dextran were significantly higher than in the controls and remained high throughout the first year. Virtually all of the control babies became anemic and hemoglobin levels below 5 gm/100 ml were observed in four infants.

There was no difference in the rate of growth or in the incidence of common infections in the two groups.

It is concluded that intramuscular injections of iron given prophylactically in the nursery will effectively prevent iron-deficiency anemia in premature infants and that this practice has definite clinical applicability. (See Addendum.)

Prevention of iron deficiency anemia does not reduce the high incidence of common infections experienced by prematurely born infants.




This article has been cited by other articles:


Home page
 BMJHome page
T. Gera and H P S Sachdev
Effect of iron supplementation on incidence of infectious illness in children: systematic review
BMJ, November 16, 2002; 325(7373): 1142 - 1142.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
I J Griffin, M M Reid, K P B McCormick, and R J Cooke
Zinc protoporphyrin/haem ratio and plasma ferritin in preterm infants
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2002; 87(1): F49 - 51.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. J. Oppenheimer
Iron and Its Relation to Immunity and Infectious Disease
J. Nutr., February 1, 2001; 131(2): 616S - 635.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
I. J Griffin, R. J Cooke, M. M Reid, K. P B McCormick, and J. S Smith
Iron nutritional status in preterm infants fed formulas fortified with iron
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 1999; 81(1): 45F - 49.
[Abstract] [Full Text]